Surgeon-Performed Ultrasound Is Superior to 99Tc-Sestamibi Scanning to Localize Parathyroid Adenomas in Patients with Primary Hyperparathyroidism: Results in 516 Patients over 10 Years
- 30 April 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 212 (4), 522-529
- https://doi.org/10.1016/j.jamcollsurg.2010.12.038
Abstract
Background Surgeon-performed cervical ultrasound (SUS) and 99Tc-sestamibi scanning (MIBI) are both useful in patients with primary hyperparathyroidism (PHPT). We sought to determine the relative contributions of SUS and MIBI to accurately predict adenoma location. Study Design We performed a database review of 516 patients undergoing surgery for PHPT between 2001 and 2010. SUS was performed by 1 of 3 endocrine surgeons. MIBI used 2-hour delayed anterior planar and single-photon emission computerized tomography images. Directed parathyroidectomy was performed with extent of surgery governed by intraoperative parathyroid hormone decline of 50%. Results SUS accurately localized adenomas in 87% of patients (342/392), and MIBI correctly identified their locations in 76%, 383/503 (p < 0.001). In patients who underwent SUS first, MIBI provided no additional information in 92% (144/156). In patients who underwent MIBI first, 82% of the time (176/214) SUS was unnecessary (p = 0.015). In 32 patients SUS was falsely negative. The reason for these included gland location in either the deep tracheoesophageal groove (n = 9) or the thyrothymic ligament below the clavicle (n = 5), concurrent thyroid goiter (n = 4), or thyroid cancer (n = 1). In 13 cases, the adenoma was located in a normal ultrasound-accessible location but was missed by the preoperative exam. In the 32 ultrasound false-negative cases, MIBI scans were positive in 21 (66%). Of the 516 patients, 7.6% had multigland disease. Persistent disease occurred in 4 patients (1%) and recurrent disease occurred in 6 (1.2%). Conclusions When performed by experienced surgeons, SUS is more accurate than MIBI for predicting the location of abnormal parathyroids in PHPT patients. For patients facing first-time surgery for PHPT, we now reserve MIBI for patients with unclear or negative SUS.Keywords
This publication has 16 references indexed in Scilit:
- Surgeon-performed ultrasound: A single institution experience in parathyroid localizationSurgery, 2009
- Impact of 25-Hydroxyvitamin D Deficiency on Perioperative Parathyroid Hormone Kinetics and Results in Patients with Primary HyperparathyroidismSurgery, 2007
- Parathyroid Adenoma Localization: Surgeon‐Performed Ultrasound Versus SestamibiThe Laryngoscope, 2006
- Surgeon-Performed Ultrasonography as the Initial and Only Localizing Study in Sporadic Primary HyperparathyroidismJournal of the American College of Surgeons, 2006
- Minimally invasive procedure for resection of a parathyroid adenoma: The role of preoperative high-resolution ultrasonographyJournal of Clinical Ultrasound, 2005
- Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidismSurgery, 2004
- Cost-Effectiveness of Preoperative Sestamibi Scan for Primary Hyperparathyroidism Is Dependent Solely upon the Surgeon’s Choice of Operative ProcedureJournal of the American College of Surgeons, 1998
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1991
- Improved vertebral fracture threshold in postmenopausal osteoporosis by radiogrametric measurements: Its usefulness in selection for preventive therapyJournal of Bone and Mineral Research, 1991
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989